Efficacy and Safety of the "Neo Pill" Device for Keeping Oral Hygiene in Patients with Fixed Orthodontic Appliance
NEOPILL
1 other identifier
observational
143
1 country
1
Brief Summary
Background: Orthodontic appliances interfere with oral hygiene and contribute to plaque retention, gingival inflammation and demineralization of enamel. Current techniques for keeping oral hygiene (teeth brushing, rinsing oral cavity with 0.12% chlorhexidine, dental floss, interdental brush, Miswak) are not sufficiently effective (1). Up to 78% of patients do not follow instructions to keep oral hygiene with current methods which require discipline and effort (2). There is great need for some simple medical device to keep oral hygiene in an effective, safe and easy-to-use way. Objective: To evaluate efficacy and safety of NeoPill electrolysis device for keeping oral hygiene in patients with fixed orthodontic appliances. Hypotheses: (1) NeoPill electrolysis device in addition to standard oral hygiene techniques improves values of oral health indices (gingival bleeding index, papillary bleeding index, plaque index, and ortho-plaque index) and is associated with fewer white spots on enamel during and after 6 months of use in comparison to standard oral hygiene techniques only; (2) the adverse event rates in patients using the NeoPill electrolysis device and in patients keeping oral hygiene only with standard techniques is not significantly different; (3) quality of life in patients using the NeoPill electrolysis device is higher than in patients keeping oral hygiene only with standard techniques. Methods: The study is designed as prospective cohort investigation. Primary outcomes of the study are: the Turesky Modified Quigley Hein Plaque Index (TQHPI) for both anterior and posterior teeth Gingival Inflammation Score (GIS) for both anterior and posterior teeth, Papillary bleeding index (PBI), Ortho-Plaque Index (OPI), number of white spots on enamel, and safety (incidence of adverse events). Secondary outcomes are quality of life and overall costs of keeping oral hygiene. Main independent variable in the study is administration of the NeoPill electrolysis device produced by start-up innovative company Laviefarm, Belgrade, Serbia. The device causes detachment of bacteria from fixed orthodontic appliances and teeth, which are then washed out with mouth rinse, and swallowed or spitted out. Implications and significance: If proved effecive and safe, the NeoPill electrolysis device will make major contribution to improvement of oral hygiene in patients with fixed orthodontic appliances.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2026
ExpectedFebruary 19, 2025
February 1, 2025
1.4 years
February 10, 2025
February 18, 2025
Conditions
Outcome Measures
Primary Outcomes (6)
1. The Turesky Modified Quigley Hein Plaque Index (TQHPI) for both anterior and posterior teeth
This is the scale (questionnaire), unit of measurement is the score of the scale.
6 months
2. Gingival Inflammation Score (GIS) for both anterior and posterior teeth
This is the scale (questionnaire), unit of measurement is the score of the scale.
6 months
Papillary bleeding index (PBI)
This is the scale (questionnaire), unit of measurement is the score of the scale.
6 months
Ortho plaque index
This is the scale (questionnaire), unit of measurement is the score of the scale.
6 months
Number of white spots on enamel
It is measured by direct observation of the teeth; the unit of measurement is number of white spots.
6 months
Safety (incidence of adverse events)
Adverse events are recorded by direct observation and interview with the patients. Unit of measurement is number of adverse events.
6 months
Secondary Outcomes (1)
Costs of treatment
6 months
Study Arms (2)
Neo Pill group
The Neo Pill group include patients with fixed orthodontic appliance who will use Neo Pill device for improving oral hygiene.
Control group
The Control group will include patients with fixed orthodontic appliance who will not use Neo Pill device, but will keep oral hygiene in conventional way (toothbrush, etc.)
Eligibility Criteria
Adult patients with Fixed orthodontic appliance in place
You may qualify if:
- Provision of signed and dated informed consent form
- Fixed orthodontic appliance in place for at least 15 days
- Aged 18 years or above
- Good general health
- Permanent dentition
- Less than 5 mm of anterior crowding or spacing with adequate overjet and overbite
- Ability to maintain adequate oral hygiene
- Optimum dental health without immediate need for any allied dental procedure
You may not qualify if:
- Pregnancy, anticipated pregnancy, or breastfeeding
- Incarceration or institutionalized living
- Participation in another clinical study
- Life expectancy \<4 months
- Patients with moderate to severe renal insufficiency (acute or chronic) with glomerular filtration rate of less than 30 ml/min
- Patients with active bronchospastic disorders
- Heart failure classes III and IV
- Active dental caries
- Active periodontal disease
- Chronic systemic diseases
- Using antibiotics within the last 30 days
- Skeletal anteroposterior discrepancies between the maxilla and the mandible (ANB equal or above 5 degrees)
- Centric relation-centric occlusion discrepancies greater than 3 mm
- Patients with pace-makers and other implanted devices that require stable supply by electric energy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Kragujevac, Faculty of Medical Sciences
Kragujevac, Serbia, 34000, Serbia
Study Officials
- STUDY CHAIR
Slobodan Janković, DSc, MD
University of Kragujevac, Faculty of Medical Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associated Professor
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 19, 2025
Study Start
July 1, 2024
Primary Completion
December 1, 2025
Study Completion (Estimated)
November 1, 2026
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share